NCT07323017Active, not recruiting
Electrochemotherapy in Musculoskeletal Tumors
Electrochemotherapy in Musculoskeletal Tumors: A Quantitative Assessment of Tumor Size Variations and Treatment-related Pain Reduction.
Source: ClinicalTrials.gov · Last updated 14 Jan 2026
Brief summary (registry, in English)
The study involves the enrollment of patients over 2 years of age with a diagnosis of musculoskeletal tumors and an indication for electrochemotherapy, treated at the Rizzoli Orthopaedic Institute in Bologna and followed during outpatient follow-up. Data will be collected from medical records, outpatient reports, and imaging studies including CT, X-ray, MRI, and/or PET. For the retrospective part of the study, patients treated at the Rizzoli Orthopaedic Institute from 01/01/2024 to the date of approval of this study will be included. For the prospective part, patients meeting the inclusion criteria and treated from the study start date until 31/12/2030 will be enrolled.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 10 Dec 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 30 Dec 2030
- Lead sponsor
- Costantino Errani
- Diseases
- Childhood cancers
- NCT number
- NCT07323017
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Aug 2025 to the primary completion date, 30 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Failure to meet at least one of the inclusion criteria
Who the study is looking for
- Patients of both sexes with a histological diagnosis of a primary musculoskeletal tumor, either benign or malignant, located outside the abdominal cavity (trunk and limbs)
- Indication for electrochemotherapy due to one of the following conditions:
- Clinical conditions contraindicating surgery
- Tumor not surgically resectable
- Patients treated with electrochemotherapy at the Rizzoli Orthopaedic Institute:
- From 01/01/2024 to the date of study approval for the retrospective phase
- From the date of study approval to 12/31/2030 for the prospective phase
- Retrospectively treated patients with a minimum follow-up of at least 3 months
- Age ≥ 2 years at the time of treatment
- Availability of clinical and instrumental data
Age in the registry: 2 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Istituto ortopedico Rizzoli Coordinator of this site? Confirm its status | Bologna | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.